Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.pone.0123572 http://scihub22266oqcxt.onion/10.1371/journal.pone.0123572 C4400137!4400137!25881125     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       PLoS+One 2015 ; 10 (4): ä Nephropedia Template TP {{tp|p=25881125|t=2015. Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients |pdf=|usr=}}{{25881125}} gab.com Text Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients JO: PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=25881125 #FOAvip In cross-sectional studies autoantibodies against complement C1q (anti-C1q) were found to be highly associated with active lupus nephritis. The aim of this retrospective study was to determine the value of anti-C1q as follow-up marker of disease activity and renal involvement in patients with systemic lupus erythematosus (SLE). Fifty-two patients with SLE and a minimum of three anti-C1q measurements during follow-up were analyzed. Anti-C1q levels correlated with global disease activity scores. In subgroup analyses, patients without renal involvement did not show a significant correlation between anti-C1q levels and disease activity. In contrast, in patients with renal involvement, anti-C1q levels correlated well with global disease activity. In addition, a positive correlation with the urine protein-to-creatinine ratio and anti-dsDNA antibody levels as well as a negative correlation with complement levels was observed. Anti-C1q antibodies were found to strongly correlate with parameters of SLE disease activity during follow-up, in particular with regard to renal involvement. Twit Text FOAVip Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients ????PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=25881125 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25881125 #FOAvip English Wikipedia <ref>{{Cite pmid|25881125}}</ref> Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients #MMPMID25881125 Bock M; Heijnen I; Trendelenburg M PLoS One 2015[]; 10 (4): ä PMID25881125show ga In cross-sectional studies autoantibodies against complement C1q (anti-C1q) were found to be highly associated with active lupus nephritis. The aim of this retrospective study was to determine the value of anti-C1q as follow-up marker of disease activity and renal involvement in patients with systemic lupus erythematosus (SLE). Fifty-two patients with SLE and a minimum of three anti-C1q measurements during follow-up were analyzed. Anti-C1q levels correlated with global disease activity scores. In subgroup analyses, patients without renal involvement did not show a significant correlation between anti-C1q levels and disease activity. In contrast, in patients with renal involvement, anti-C1q levels correlated well with global disease activity. In addition, a positive correlation with the urine protein-to-creatinine ratio and anti-dsDNA antibody levels as well as a negative correlation with complement levels was observed. Anti-C1q antibodies were found to strongly correlate with parameters of SLE disease activity during follow-up, in particular with regard to renal involvement. äAnti-C1q Antibodies as a Follow-Up Marker in SLE Patients (epmc).pdf DeepDyve Pubget Overpricing